Abstract:Aims: Angiopoietin-like protein 8 (ANGPTL8) plays important roles in lipid metabolism, glucose metabolism, inflammation, and cell proliferation and migration. Clinical studies have indicated that circulating ANGPTL8 concentrations are increased in patients with hypertension and positively associated with blood pressure. ANGPTL8 deficiency ameliorates blood pressure in mice treated with chronic intermittent hypoxia. Currently, little is known regarding the pathophysiological role of the vascular smooth muscle cell (VSMC)-derived ANGPTL8 in hypertension and hypertensive cardiovascular remodelling. Methods and results: Circulating ANGPTL8 concentrations, as determined by enzyme-linked immunosorbent assay, were significantly higher in hypertensive patients than in controls (524.51 ± 26.97 vs. 962.92 ± 15.91 pg/mL; P < 0.001). In hypertensive mice [angiotensin II (AngII) treatment for 14 days] and spontaneously hypertensive rats, ANGPTL8 expression was increased and predominantly located in VSMCs. In AngII-treated mice, systolic and diastolic blood pressure in Tagln-Cre-ANGPTL8fl/fl mice were approximately 15-25 mmHg lower than that in ANGPTL8fl/fl mice. AngII-induced vascular remodelling, vascular constriction, and increased expression of cell markers of proliferation (PCNA and Ki67) and migration (MMP-2 and MMP-9) were strikingly attenuated in Tagln-Cre-ANGPTL8fl/fl mice compared with ANGPTL8fl/fl mice. Furthermore, the AngII-induced increase in the heart size, heart weight, heart/body weight ratio, cardiomyocyte cross-sectional area, and collagen deposition was ameliorated in Tagln-Cre-ANGPTL8fl/fl mice compared with ANGPTL8fl/fl mice. In rat artery smooth muscle cells, ANGPTL8-short hairpin RNA decreased intracellular calcium levels and prevented AngII-induced proliferation and migration through the PI3K-Akt pathway, as shown using LY294002 (inhibitor of PI3K) and Akt inhibitor VIII. Conclusion: This study suggests that ANGPTL8 in VSMCs plays an important role in AngII-induced hypertension and associated cardiovascular remodelling. ANGPTL8 may be a novel therapeutic target against pathological hypertension and hypertensive cardiovascular hypertrophy.

Angiopoietin-Like 7 Contributes to Angiotensin II-Induced Proliferation, Inflammation and Apoptosis in Vascular Smooth Muscle Cells.

Vascular smooth muscle cells specific deletion of angiopoietin-like protein 8 prevents angiotensin II-promoted hypertension and cardiovascular hypertrophy

Inhibition of PTEN Expression and Activity by Angiotensin II Induces Proliferation and Migration of Vascular Smooth Muscle Cells

Angiotensin II prompts heart cell apoptosis via AT1 receptor-augmented phosphatase and tensin homolog and miR-320-3p functions to enhance suppression of the IGF1R-PI3K-AKT survival pathway

Angiotensin II-induced Matrix Metalloproteinase-8 is Regulated by Angiotensin-(1-7) in Vascular Smooth Muscle Cells

Different Effects Of Angiotensin Ii And Angiotensin-(1-7) On Vascular Smooth Muscle Cell Proliferation And Migration

Angiotensin-(1-7) Attenuates Angiotensin II-Induced ICAM-1, VCAM-1, and MCP-1 Expression via the MAS Receptor Through Suppression of P38 and NF-κB Pathways in HUVECs

ANG II induces apoptosis of human vascular smooth muscle via extrinsic pathway involving inhibition of Akt phosphorylation and increased FasL expression.

ANGPTL8 is a negative regulator in pathological cardiac hypertrophy

Angiotensin-(1–7) Regulates Angiotensin II-induced VCAM-1 Expression on Vascular Endothelial Cells

The Role of Angiopoietin-like Protein 4 in Phenylephrine-induced Cardiomyocyte Hypertrophy.

Regulation of angiotensin II-Induced Krüppel-like factor 5 expression in vascular smooth muscle cells.

Angiopoietin-like protein 8 accelerates atherosclerosis in ApoE−/− mice

ANGPTL7 regulates the expansion and repopulation of human hematopoietic stem and progenitor cells.

Angiotensin-(1-7) Mitigated Angiotensin II-induced Abdominal Aortic Aneurysms in Apolipoprotein E-knockout Mice.

Angiotensin II Upregulates the Expression of Placental Growth Factor in Human Vascular Endothelial Cells and Smooth Muscle Cells

Overexpression of TRPM7 Suppresses AngII-induced Phenotypic Changes in Hypertensive Human Vascular Smooth Muscle Cells

Angiotensin-(1–7) Dose-Dependently Inhibits Atherosclerotic Lesion Formation and Enhances Plaque Stability by Targeting Vascular Cells

Angiopoietin-Like Protein 7 and Short-Term Mortality in Acute Heart Failure.

Hypoxia inducible factor 1α in vascular smooth muscle cells promotes angiotensin II-induced vascular remodeling via activation of CCL7-mediated macrophage recruitment.

Involvement Of Profilin-1 In Angiotensin Ii-Induced Vascular Smooth Muscle Cell Proliferation